DOCUMENT
Supplementary table 2.docx (16.66 kB)
DOCUMENT
Supplementary table 1.docx (32.76 kB)
1/0
Comparing Bacillus Calmette-Guérin (BCG) strains in convalescent COVID-19 patients. Supplementary tables
dataset
posted on 2023-01-11, 08:53 authored by Leonardo O. Reis, Adilson P Domingues-Junior, Reza Yadollahvandmiandoab, Cristiane L Maia, Franciele AV Dionato, Luciana SB Dal Col, Keini Buosi, Patricia AF Leme, Cristiane F Giacomelli, Mehrsa Jalalizadeh
Supplementary Table 1. COVID-19 symptom progression. P-Value is calculated using Fisher’s exact test comparing BCG-R (Russia) to BCG-B (Brazil). Placebo data is provided for comparison. Lesion type is compared between two groups using Fisher’s exact test showing a slightly higher probability of pustule formation during the first week in the BCG-Brazil group.
Supplementary Table 2. There are six trials comparing effect of various strains of BCG including: BCG-Japan, BCG-Russia, BCG-Russia-I (Serum Institute of India), BCG-Denmark 1331, BCG-Tice, BCG- Connaught, BCG-Tokyo-172, BCG-Denmark culture (SSI), on Heterologous Immunity, Infant Morbidity, Infant Mortality, Trained Immunity, Vaccine Reaction, and Bladder Urothelial Carcinoma.
